Kennedy's rationale is based on a series of inaccuracies and part of a pattern of misrepresentation.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Repeat SARS-CoV-2 infections confer significant additional risk of adverse multi-organ medical conditions and poor outcomes such as hospitalization, diabetes, kidney disease, mental illness, death, and diseases affecting the lungs, heart, brain, blood, and musculoskeletal systems, suggests a study published yesterday in Nature Medicine.
Kids were 30% more likely than controls to have symptoms 3 month or more after COVID-19.
Some European firms are closing or scaling back operations, fueling fears of shortages of essential drugs.
Weekly COVID-19 hospitalizations of infants younger than 6 months rose 11-fold from April to July 2022.
JAMA Network Open published a new study yesterday showing higher cord blood COVID-19 antibodies in women who were vaccinated compared with those who were infected with COVID-19, suggesting vaccination produces more than 10-fold higher antibody concentrations in unborn babies compared to natural infections.
Study reveals disparities in access to sites—and thus antivirals—with 15% living more than an hour away.
Southeast Asia and the Western Pacific saw modest rises, but cases are down worldwide.
An observational study published this week in eClinicalMedicine suggests that COVID-19–related acute kidney injury (AKI) is tied to a greater risk of death, and that severe AKI may lead to poor recovery of kidney function.
A study of US patients aged 0 to 20 years hospitalized for COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in 2020 and 2021 shows that 22% had a neurologic condition, including 9% with life-threatening illness.
Myocarditis and pericarditis are rare after COVID vaccination, but rates were twofold to threefold higher after receipt of the second dose of the Moderna vaccine than after the Pfizer version.
